ストックスクリーナーアプリを入手
1.63
10.14%
0.15
アフターアワーズ：
1.61
-0.02
-1.23%
Invivyd Inc (IVVD) 最新ニュース
Invivyd, Inc. (NASDAQ:IVVD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Invivyd prices $125M stock offering at $2.50 per share - MSN
Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE) - The Globe and Mail
H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback - Investing.com Nigeria
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial - Investing.com Nigeria
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial By Investing.com - Investing.com South Africa
Invivyd rises as FDA agrees with late-stage trial design for COVID-19 therapy - Seeking Alpha
Invivyd aligns with FDA for Phase 3 vaccine trial - Traders Union
Invivyd rises on late-stage trial testing COVID antibody against mRNA vaccines - TradingView
Invivyd, Inc. Announces FDA Alignment on LIBERTY Phase 3 Clinical Trial for VYD2311, a Monoclonal Antibody Candidate for COVID-19 Prevention - Quiver Quantitative
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration - The Manila Times
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 ... - Caledonian Record
FDA asks Invivyd to track myocarditis in new COVID antibody vs vaccine trial - Stock Titan
Invivyd Reports Strong Q3 Growth and Strategic Advances - MSN
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Update - MarketBeat
Invivyd, Inc.'s (NASDAQ:IVVD) 26% Share Price Plunge Could Signal Some Risk - simplywall.st
Institutional investors in Invivyd, Inc. (NASDAQ:IVVD) see US$113m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Invivyd shares edge higher on education campaign with Olympic star Lindsey Vonn - MSN
HC Wainwright Predicts Invivyd FY2030 Earnings - MarketBeat
How Recent Price Target Resets Are Rewriting The Story For Invivyd (IVVD) - Yahoo Finance
H.C. Wainwright reaffirms Buy rating on Invivyd stock ahead of key trial data By Investing.com - Investing.com Nigeria
Aug Fed Impact: Should you avoid Invivyd Inc stock right now2025 Breakouts & Breakdowns & Consistent Growth Equity Picks - baoquankhu1.vn
H.C. Wainwright reaffirms Buy rating on Invivyd stock ahead of key trial data - Investing.com
Analysts Are Bullish on These Healthcare Stocks: Invivyd (IVVD), Alignment Healthcare (ALHC) - The Globe and Mail
Invivyd partners with ski champion Lindsey Vonn on antibody education By Investing.com - Investing.com Nigeria
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Invivyd partners with ski champion Lindsey Vonn on antibody education - Investing.com
Invivyd stock rises after partnering with Olympic champion Lindsey Vonn By Investing.com - Investing.com Canada
Invivyd partners with Lindsey Vonn to educate Americans on antibodies and disease prevention - marketscreener.com
Invivyd Announces Partnership with World Champion Skier - GlobeNewswire
Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention - Finviz
Invivyd stock maintains Buy rating at BTIG on Long COVID treatment potential - Investing.com UK
Invivyd stock maintains Buy rating at BTIG on Long COVID treatment potential By Investing.com - Investing.com Nigeria
Invivyd to begin phase 2 trial of antibody therapy for long COVID - Investing.com Nigeria
Invivyd to begin phase 2 trial of antibody therapy for long COVID By Investing.com - Investing.com South Africa
Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026 - The Manila Times
Invivyd Initiates Phase 2 Trial for VYD2311 Targeting Long COVID Patients - Intellectia AI
Experimental COVID antibody trial targets Long COVID and vaccine injury by 2026 - Stock Titan
Short Interest in Invivyd, Inc. (NASDAQ:IVVD) Grows By 24.4% - MarketBeat
Bull Run: What is the target price for Invivyd Inc stockMarket Volume Summary & Safe Entry Trade Reports - baoquankhu1.vn
Invivyd, Inc.'s (NASDAQ:IVVD) Business Is Trailing The Industry But Its Shares Aren't - 富途资讯
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Invivyd (IVVD) Reports Strong Q4 Growth, Advances COVID Antibody to Phase 3 - Insider Monkey
0.36%
1.16%
大文字化:
|
ボリューム (24 時間):